Cory S. Freedland
CIK: 0001832569
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NGNE
Neurogene Inc.
Director
Discretionary Trading P&L
Holdings
About Freedland Cory S.
Freedland Cory S. (SEC CIK 0001832569) files insider reports with the SEC as Director of Neurogene Inc. (NGNE).
Signal8 holds 2 ownership filings by Freedland Cory S., all Form 4s, filed between Jun 13, 2025 and Feb 24, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Feb 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Freedland Cory S.'s filings is in NEW YORK, NY.
Recent filings by Freedland Cory S.
Other insiders filing for Neurogene Inc. (NGNE)
- McMinn Rachel, Chief Executive Officer
- Cvijic Christine Mikail, President and CFO
- Woods Keith, Director
- Shafer Christina, Chief Commercial Officer
- Jordan Julie, Chief Medical Officer
- Cobb Stuart, Chief Scientific Officer